Home › Funds › BIOS Capital Management, LP › INAB

BIOS Capital Management, LP position in INAB

IN8BIO INC · Health Care

BIOS Capital Management, LP reported holding 80,957 shares of INAB (IN8BIO INC) in its Q3 2026 13F filing — a position valued at US$107.7M, representing 0.32% of its reported portfolio and ranking #6 among its reported holdings. BIOS Capital Management, LP has disclosed INAB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)80.96K sh
Reported value held$107.67M
Portfolio Weight0.32%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How BIOS Capital Management, LP's INAB position evolved

BIOS Capital Management, LP first disclosed a stake in INAB in Q4 2024 at 8,600,001 shares (US$2.2M). The position peaked in Q3 2026 at 80,957 shares, worth US$107.7M. Across 8 filings, BIOS Capital Management, LP increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 80,957 shares valued at US$107.7M. Notable position changes include a 97% trim in Q2 2025 (shares rose 4% over the following quarter), a 34% trim in Q1 2026 (shares fell 5% over the following quarter), a 52% trim in Q2 2026 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 8.60M $2.21M New
Q1 2025 8.60M $1.43M Hold
Q2 2025 286.66K $599.13K Reduce
Q3 2025 286.66K $622.06K Hold
Q4 2025 253.42K $593.00K Reduce
Q1 2026 167.81K $248.35K Reduce
Q2 2026 80.96K $114.15K Reduce
Q3 2026 80.96K $107.67M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INAB and 13F data

INAB (IN8BIO INC) is a Health Care company. 23 other funds we track also report a position in INAB — the largest reported positions include Stonepine Capital Management, LLC (US$928K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INAB

All INAB fund holders →

FAQ

How long has BIOS Capital Management, LP held INAB?

BIOS Capital Management, LP has disclosed INAB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is BIOS Capital Management, LP's current position in INAB?

As of Q3 2026, BIOS Capital Management, LP holds 80.96K shares of INAB (IN8BIO INC), valued at $107.67M, representing 0.32% of its reported portfolio and ranking #6.

Has BIOS Capital Management, LP been buying or selling INAB?

In the latest 13F filing (Q3 2026), BIOS Capital Management, LP held unchanged its position in INAB. The position peaked in Q3 2026 at 80.96K shares.

Which other funds hold INAB?

Other major institutional holders of INAB include Stonepine Capital Management, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.